Liver Metastasis Irradiation Can Restore Immunotherapeutic Responsiveness
- PMID: 33637449
- DOI: 10.1016/j.it.2021.02.007
Liver Metastasis Irradiation Can Restore Immunotherapeutic Responsiveness
Abstract
Allogeneic liver transplants tolerize the immune system, preventing organ rejection from the same donor. A recent article by Yu et al. shows that liver metastases can likewise prevent tumor rejection in immunotherapy-treated murine and human hosts. Furthermore, radiation can reprogram the liver microenvironment to restore systemic tumor rejection.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Interests The authors declare that they have no competing interests related to this work. However, S.D. has received research support from Lytix Biopharma and consultant fees from Lytix Biopharma and Ono Pharmaceuticals. S.C.F. has received prior honorarium for consulting/speaker from AstraZeneca, Merck, Regeneron, Bayer, Serono, and research funding from Varian, Merck, Bristol Meyer Squibb.
Comment on
-
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination.Nat Med. 2021 Jan;27(1):152-164. doi: 10.1038/s41591-020-1131-x. Epub 2021 Jan 4. Nat Med. 2021. PMID: 33398162 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
